ClinicalTrials.gg
RecruitingNCT07281651Pain-DriveUpdated Dec 15, 2025

Investigating the Role of Central Pain Hypersensitivity in Skeletal Muscle Neural Drive

An observational study in Chronic Knee Pain and Fibromyalgia, sponsored by University of Nottingham. Recruiting at 1 site in United Kingdom. Open to participants aged 40 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-15.

Sponsored by University of Nottingham · Observational

How we know

From the registry’s dates

  • Started Nov 2025; still recruiting 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
135
Ages
40 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 31 studies in Fibromyalgia with a site in United Kingdom — 4 open to participants now, 6 under way, none of them phase 3. Fibromyalgia · United Kingdom.

Started
2025
with 1 other
Observational
9 of 31
2 open now
Registered
28th of 31
by date
Lead sponsor
2 of 31
University of Nottingham

Among the 31 studies in Fibromyalgia with a site in United Kingdom, this one is one of 2 that started in 2025, is one of 9 observational ones, and was the 28th registered.

Fibromyalgia

1,245 studies on the registry are indexed under Fibromyalgia; 256 are open to participants now.

Browse Fibromyalgia studies →

Open to participants now

4 of the 31 studies in Fibromyalgia with a site in United Kingdom are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 161 Fibromyalgia studies recruiting now, 51 (32%) set no upper age limit and 96 (60%) stop at 75 or younger; 15 take children under 18; 35 take healthy volunteers.

This study: 40 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 31 studies in Fibromyalgia with a site in United Kingdom, or all of them as a file.
02

Study summary

Background: pain lasting for 12 weeks or beyond, which is often referred to as chronic pain, is common for people living with musculoskeletal conditions (e.g. arthritis, low back pain and fibromyalgia). Pain is often not directly related to the degree of muscle or joint damage. Adaptations of the central nervous system (brain, spinal cord and nerves) often occur in chronic musculoskeletal conditions and can influence how we feel pain (central pain hypersensitivity). Pain can impact on muscle activity and movement. Muscle activity is also governed by nerve signals from the central nervous system (neural drive).

The goal of this cross-sectional observational study is to investigate whether chronic musculoskeletal pain is associated with altered nerve signalling (neural drive) to skeletal muscles in adults 40 years or over with chronic knee pain, fibromyalgia and healthy pain free volunteers.

The main questions it aims to answer are:-

  • Is central pain hypersensitivity associated with altered nerve signalling to skeletal muscles in adults 40 years or over with chronic pain (knee pain and for fibromyalgia) as well as healthy volunteers?
  • Is altered nerve signalling to skeletal muscles associated with physical function and disability?

Participants will be asked to:-

  • Have sensory testing to determine how they feel pain
  • Complete static leg and arm muscle contractions with electrodes on the skin to measure muscle electrical activity
  • Complete questionnaires
  • Perform a short set of mobility tasks including walking, rising from a chair and balancing.
Read the detailed description

Participants will be required to attend two visits to Derby Medical School.

Screening and eligibility assessment:- Prior to booking an appointment to attend the study, potential participants will be given the opportunity to ask questions and be pre-screened for eligibility for the study.

Participation involves two study visits:- Visit 1 involves screening for eligibility, and providing informed consent. A brief history of pain condition and clinical knee assessment will be carried out. Familiarisation with the muscle testing protocol (practicing a set of muscle contractions) a questionnaire booklet will be provided at this visit. Visit 1 will last between 30 and 45 minutes.

Visit 2 is the test session. Body weight and height will be taken. Pain sensitivity testing (quantitative sensory testing) will be followed by neuromuscular testing while sitting in a specially designed chair. Isometric muscle contractions will be measured using an isometric dynamometer. One muscle will be tested in the lower legs and one muscle in the upper arms (on both sides).

Electrodes will be placed on a muscle at the front of the leg (tibialis anterior) and at the front of the upper arm (biceps brachii). A battery of isometric (static) muscle contractions will be performed following a force trace visual feedback on a monitor. To test whether experimental remote pain has an influence on neuromuscular functioning, a temporary pain stimulus will be applied to the arm via blood pressure cuff to a subjective level of 4/10 where '0' no pain and '10' worse pain or discomfort imaginable. A series of muscle contractions will be carried out during the remote discomfort stimulus lasting approximately 2 minutes. If discomfort becomes too much at any time the cuff will be removed immediately.

Physical performance and self-reported physical functioning and disability will be measured with a simple performance measure and questionnaires respectively. A pre-test questionnaire will be used to collect relevant data, including: pain severity, duration of pain condition, duration of pain, other medical conditions, gender, ethnicity, smoking status, employment status, use of pain medications. The questionnaire also includes validated questionnaires on quality of life, central aspects of pain, disability, physical functioning, fatigue and physical activity.

03

Conditions studied

  • Chronic Knee Pain
  • Fibromyalgia

Keywords

  • Chronic Pain
  • Musculoskeletal Conditions
  • Fibromyalgia
  • Muscle Function
  • Physical Functioning
  • Disability
  • Central Aspects of Pain
04

Who can participate

Ages eligible
40 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Participants may be recruited via various routes. Recruitment will primarily be through the Investigating Musculoskeletal Health and Wellbeing (IMH\&W) cohort, which comprises over 7610 people with and without a range of musculoskeletal conditions. Participants with knee pain or fibromyalgia or healthy pain free individuals may be recruited via word of mouth, via University of Nottingham intranet and posters. Participant with fibromyalgia may be recruited to take part via local community support groups.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Knee pain group

  • History of knee pain with an intensity level of 4 out of 10 or greater (where 0 is no pain and 10 is the worst pain imaginable) for most days in the past 3 months

Fibromyalgia group

  • Fibromyalgia diagnosis (participant self-reporting a previous diagnosis by a clinician)
  • Pain with an intensity level of 4 out of 10 or greater (where 0 is no pain and 10 is the worst pain imaginable) for most days in the past 3 months

Control group

- Pain free individuals without known osteoarthritis

Exclusion criteria

Exclusion Criteria:

  • >35
  • Body weight of 250kg or higher
  • Pregnancy (women)
  • Inability to give consent
  • Inability to meet the requirements of clinical assessment
  • Performed strenuous physical exercise in the past 24 hours prior to testing
  • Consumed alcohol on day of testing
  • Consumed caffeine on day of testing
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
135 participants (estimated)
Patient registry
No

Groups and cohorts

  • Chronic Knee Pain

    Adults with knee pain lasting over 3 months

    Other: Central Pain Hypersensitivity

  • Fibromyalgia

    Adults with Fibromyalgia

    Other: Central Pain Hypersensitivity

  • Control Group

    Adults without chronic pain conditions

    Other: Central Pain Hypersensitivity

Interventions

  • OtherCentral Pain Hypersensitivity

    No intervention carried out

06

What researchers measure

Primary outcomes

  1. Pressure Pain Threshold

    Pressure Pain Threshold as an index of central pain hypersensitivity. Pressure Pain Threshold (PPT) performed with digital algometer, applied at proximal forearm. A gradually increasing pressure is applied, and participants indicate when the sensation of pressure turns to pain. PPDT measured in Kilopascals (kPa). Three tests applied, which are then mean averaged. Lower PPT indicates greater pain sensitivity.

    Time frame: Once at baseline

  2. Temporal Summation

    Temporal Summation as an index of central pain hypersensitivity. Temporal Summation (TS) assessed using a puncate stimulator (designed not to puncture the skin). Participants rate their experience of sharpness during the stimulus on a 10 cm visual analogue scale, first following one application, and second following 10 repeated applications. TS is calculated by subtracting first score from second (in cm). Higher positive scores indicate higher sensitivity.

    Time frame: Once at baseline

  3. Conditioned Pain Modulation

    Conditioned Pain Modulation as an index of central pain hypersensitivity. Conditioned pain modulation (CPM) involves temporary ischaemic pain at one arm by way of blood pressure cuff. PPT simultaneously applied to opposite forearm. CPM calculated as conditioned PPT minus non-conditioned PPT in kilopascals (kPa). Lower positive or negative CPM indicates higher sensitivity.

    Time frame: Once at baseline

  4. Short Physical Performance Battery Test

    A measure of physical performance of basic physical tasks, which is made up of for tasks:- Standing balance: participants are timed as to how long they can maintain standing balance unassisted without walking aids. First with feet side by side, second in semi-tandem stance, third in full tandem-stance. Points are awarded if balance is maintained for 10 seconds. Walking speed: participants are timed to walk a short distance (3 or 4 meters) at their usual walking pace. Allowed to use their usual walking aids. Points are awarded based on pre-set time scales for completing the walk. Repeated sit to stand: participants timed as to how many times they can sit to stand 5 times from an average height chair. Points awarded based on pre-set durations. Points are combined to give an overall score ranging from 0 - 12. A higher overall score = higher physical performance.

    Time frame: Once at baseline

  5. Motor Unit Firing Characteristics of skeletal muscles via High Density Surface Electromyography (HDsEMG)

    Motor unit firing characteristics will be captured using HDsEMG during a range of sub-maximal skeletal muscle contractions. HDsEMG sensor will be placed on the skin over the muscles tibialis anterior and biceps brachii bilaterally to record muscle activation. Established methods will allow analysis of motor unit firing characteristics in terms of size, number, complexity, reliability and firing rate.

    Time frame: Once at baseline

Secondary outcomes

  1. Central Aspects of Pain Questionnaire

    A self completed questionnaire giving a central aspects of pain factor, an index of central nervous system aspects of pain. The questionnaire includes 8 items covering neuropathic-like pain, fatigue, cognitive difficulty, catastrophizing, anxiety, sleep disturbance, depression and widespread pain. For the former 7 items, respondents rate the frequency of experiencing symptoms over the past week with four options "never", "sometimes", "often", "always". The widespread pain item involves shading areas of a manakin relating to painful areas of the body experienced on most days in the last four weeks. All items are combined to give an overall score. Scores can range from 0 to 16. The higher the score, the greater the central aspects of pain factor.

    Time frame: Once at baseline

  2. Neuromuscular control

    A range of isometric muscle contraction patterns will be performed (tibialis anterior and biceps brachii) in terms of contraction strength, duration and rate of force generation. Neuromuscular control metrics will include force steadiness, and force accuracy.

    Time frame: Once at baseline

  3. Neuromuscular functioning alongside remote pain stimulus

    To test whether experimental remote pain has an influence on neuromuscular functioning, a temporary pain stimulus will be applied to the arm via blood pressure cuff to a subjective level of 4/10 where '0' no pain and '10' worse pain or discomfort imaginable. A series of isometric (static) muscle contractions will be carried out during the remote discomfort stimulus lasting approximately 2 minutes. If discomfort becomes too much at any time the cuff will be removed immediately. The effect of remote pain stimulus on neuromuscular functioning will be analysed in terms of neuromuscular control (including force steadiness, and force accuracy) and motor unit firing characteristics (using HDsEMG).

    Time frame: Once at baseline

  4. Pain Intensity

    Pain intensity measured by self-report using an 11 point numerical rating scale from 0-10, where 0 is no pain and 10 is the worst pain imaginable. Three items will be administered, using the 11 point scale detailed above:- * Over the past 4 weeks, how strong was your strongest pain? * Over the past 4 weeks, how strong was your pain on average? * How would you assess your pain now, at this moment?

    Time frame: Once via questionnaire prior to objective testing, however current pain level also completed on day of objective testing. Both are at baseline.

  5. RAND 36 Item Survey 1.0 - Physical Performance sub-scale (SF-36 PF)

    The RAND SF-36 PF is a sub-scale of the overall RAND SF-36 quality of life self-completed questionnaire. The SF-36 PF is a measure of Physical Functioning. There are 10 question covering a range of every day physical functioning activities. Three responses are possible regarding the level of limitation experienced for each item i.e. "not limited at all" (three points), "limited a little" (2 points) or "limited a lot" (1 point). The overall SF-36 PF score is from 0-100, where 100 indicates the most favourable health state.

    Time frame: Once at baseline.

  6. Health Assessment Questionnaire - Disability Index (HAQ-DI)

    The HAQ-DI is a self-completed questionnaire designed to measure a person's functional ability over the past week. It covers eight categories of daily activities, including:- Dressing and Grooming; Arising; Eating; Walking; Hygiene; Reach; Grip and Activities. It also asks questions on the use of aids or devices and the need for help from other people. Each item is scored from 0-3. The overall HAQ-DI score is calculated by summing all the domains, and dividing by eight, providing an ordinal score from 0 (no-disability) to 3 (severe disability).

    Time frame: Once at baseline

  7. Modified Fatigue Impact Scale (MFIS)

    The MFIS is a self-completed questionnaire which provides a measure of how fatigue impacts on daily life. It has 21 items and provides an overall score out of 84 with higher scores indicating a greater impact of fatigue. Four sub-scales can be calculated: physical, cognitive and psychosocial, indicating how much fatigue impacts on these aspects of health and wellbeing.

    Time frame: Once at baseline

  8. Physical Activity Scale for the Elderly (PASE)

    The PASE is a self-completed questionnaire which measures physical activity levels over the past 7 days. It includes activities relating to leisure, household and occupation. It provides an overall score from 0-400 or more and a higher score indicates higher levels of physical activity.

    Time frame: Once at baseline

07

Study locations

1 of 1 sites recruiting
  • University of Nottingham Graduate Entry Medicine and Health, Royal Derby Hospital, Uttoxeter Road, Derby
    Derby, Derbyshire DE22 3DT, United Kingdom
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Nov 2025 (actual). Primary completion is estimated for Sep 2026, 10 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 17, 2025
First posted
Dec 15, 2025
StartActual
Nov 24, 2025
Primary completionEst.
Sep 2026
CompletionEst.
Sep 2026
Last update
Dec 15, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 15, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07281651
Responsible party
Stephanie Smith (Dr Stephanie Smith, University of Nottingham) — Principal investigator
First posted
Dec 15, 2025
Start date
Nov 24, 2025
Primary completion
Sep 2026 (estimated)
Completion
Sep 2026 (estimated)
Last update
Dec 15, 2025

Study contacts

Ben Lightowler, MSc
Contact
benjamin.lightowler@nottingham.ac.uk
+44 (0)115 7484098
Stephanie Smith, PhD
Contact
Stephanie.Smith2@nottingham.ac.uk
+44 (0) 115 823 1942
Stephanie Smith, PhD
principal investigator · University of Nottingham
Mathew Piasecki, PhD
principal investigator · University of Nottingham

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion